Clinical Trial

Metabolomic Profiling of Patients With Traumatic Brain Injury

Recruiting
View on ClinicalTrials.gov →
Summary
Traumatic Brain Injury (TBI) is a significant cause of mortality and morbidity worldwide. However, the literature on determining its severity and predicting prognosis is insufficient. This study aimed to examine the differences in metabolite levels between trauma patients with severe TBI and orthopedic trauma patients without brain injury.
Trial Details
NCT Number NCT07292766
Lead Sponsor Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Conditions Traumatic Brain Injury, Traumatic Brain Injury (TBI) Patients
Enrollment 60 participants
Start Date 2024-02-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-18